Calamos Advisors LLC
- SEC CIK
- 0001316507
- Latest filing
- Jul 31, 2026
MIRM holding history
Mirum Pharmaceuticals, Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MIRM overviewAll 13F holders of MIRMFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,003
- Value
- $1.41M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,003 | $1.41M | <0.1% | +3,468+40.6% | Added | Holders |
| Q1 2026 | 8,535 | $788.5K | <0.1% | +8,535 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −43,250−100.0% | Sold out | Holders |
| Q3 2025 | 43,250 | $3.17M | <0.1% | +9,985+30.0% | Added | Holders |
| Q2 2025 | 33,265 | $1.69M | <0.1% | −3,389−9.2% | Reduced | Holders |
| Q1 2025 | 36,654 | $1.65M | <0.1% | +36,654 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −108,653−100.0% | Sold out | Holders |
| Q3 2022 | 108,653 | $2.28M | <0.1% | +66,132+155.5% | Added | Holders |
| Q2 2022 | 42,521 | $828.0K | <0.1% | +42,521 | New | Holders |